We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

10 hedge funds and large institutions have $1.06M invested in Vaccinex, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

12% more capital invested

Capital invested by funds: $945K → $1.06M (+$116K)

11% more funds holding

Funds holding: 9 → 10 (+1)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OC
Oppenheimer & Co
New York
+$100K
2
Creative Planning
Creative Planning
Kansas
+$64K
3
BlackRock
BlackRock
New York
+$17.3K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.67K

Top Sellers

Rank Fund Capital Flow
1
TI
Telemetry Investments
New York
-$64K
2
Millennium Management
Millennium Management
New York
-$22.7K
3
UBS Group
UBS Group
Switzerland
-$12K
4
PAM
Panagora Asset Management
Massachusetts
-$1.33K

VCNX Hedge Fund Activity: Q2 2019 in Review

10 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q2 2019, worth a combined $1.06M — up 12% from $945K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new VCNX positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Oppenheimer & Co, opening a new position worth an estimated $100K. The largest seller was Telemetry Investments, cutting an estimated $64K.

  • 10 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q2 2019, up from 9 in Q1 2019.
  • Funds reported $1.06M of Vaccinex, Inc. Common Stock stock for Q2 2019, up 12% quarter-over-quarter.
  • 2 funds opened new Vaccinex, Inc. Common Stock positions in Q2 2019 and 1 closed out, a net change of +1 holder.
  • The largest Vaccinex, Inc. Common Stock buyer in Q2 2019 was Oppenheimer & Co, an estimated $100K added.
  • The largest Vaccinex, Inc. Common Stock seller in Q2 2019 was Telemetry Investments, an estimated $64K sold.

Based on aggregated 13F filings for Q2 2019.